Bone Marrow Recovery by Morphometry during Induction Chemotherapy for Acute Lymphoblastic Leukemia in Children.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 4427405)

Published in PLoS One on May 11, 2015

Authors

Tuong-Vi Nguyen1, Anna Melville2, Shriram Nath3, Colin Story4, Stuart Howell5, Rosemary Sutton6, Andrew Zannettino7, Tamas Revesz8

Author Affiliations

1: Erasmus University, Rotterdam, The Netherlands; SA Pathology at Women's and Children's Hospital, Adelaide, Australia.
2: Women's and Children's Research Institute, Adelaide, Australia.
3: SA Pathology, Frome Road, Adelaide, Australia.
4: SA Pathology at Women's and Children's Hospital, Adelaide, Australia.
5: Data Management & Analysis Centre, Discipline of Public Health, University of Adelaide, Adelaide, Australia.
6: Children's Cancer Institute Australia, Lowy Cancer Research Centre, UNSW, Randwick, NSW, Australia.
7: Faculty of Health Science, University of Adelaide, Adelaide, Australia; Centre for Cancer Biology, SA Pathology, Adelaide, Australia.
8: SA Pathology at Women's and Children's Hospital, Adelaide, Australia; Faculty of Health Science, University of Adelaide, Adelaide, Australia.

Articles cited by this

Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell (2009) 14.40

The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol (2012) 6.07

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood (2006) 3.91

The endosteal 'osteoblastic' niche and its role in hematopoietic stem cell homing and mobilization. Leukemia (2010) 1.96

Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting. Leukemia (2007) 1.79

Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells. Blood (2010) 1.78

Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol (2010) 1.77

Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts. Blood (2014) 1.60

Bone pain as an initial symptom of childhood acute lymphoblastic leukemia: association with nearly normal hematologic indexes. J Pediatr (1990) 1.59

Advances in understanding the leukaemia microenvironment. Br J Haematol (2014) 1.19

Functional heterogeneity of the bone marrow vascular niche. Ann N Y Acad Sci (2009) 1.18

Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia. Br J Haematol (2009) 0.99

Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells. Leukemia (2007) 0.97

Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition. Oncotarget (2014) 0.89

Childhood acute lymphoblastic leukemia (ALL) presenting with severe osteolysis: a model to study leukemia-bone interactions and potential targeted therapeutics. Pediatr Hematol Oncol (2010) 0.87

Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome. Leukemia (2007) 0.85

High throughput FRET analysis of protein-protein interactions by slide-based imaging laser scanning cytometry. Cytometry A (2013) 0.84

Differential diagnosis of paediatric bone pain: acute lymphoblastic leukemia. Leuk Res (2012) 0.82

Bone histomorphometry in children with newly diagnosed acute lymphoblastic leukemia. Pediatr Res (2003) 0.81

Reticulin fibres anchor leukaemic blasts in the marrow of patients with acute lymphoblastic leukaemia. Med Hypotheses (2011) 0.80

Bone marrow fibrosis and vascular density lack prognostic significance in childhood acute lymphoblastic leukaemia. Leukemia (2010) 0.78